Annexon, Inc. logo

Annexon, Inc.

NASDAQ:ANNX

Overview | Financials
Company Name Annexon, Inc.
Symbol ANNX
Currency USD
Price 6.61
Market Cap 698,372,940
Dividend Yield 0%
52-week-range 2.27 - 8.4
Industry Biotechnology
Sector Healthcare
CEO Mr. Douglas Love Esq., J.D.
Website https://www.annexonbio.com

An error occurred while fetching data.

About Annexon, Inc.

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which

Related Stocks

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

12.35 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

15.79 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.15 USD

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

23.87 USD

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

3.45 USD

ChromaDex Corporation logo

ChromaDex Corporation

CDXC

7.25 USD

Financials

Numbers are in millions USD

Numbers are in millions USD